Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,611,120 | 1,149,759 | 722,052 | 372,268 | 2,628,501 |
| Depreciation Amortization | 1,784,339 | 1,288,432 | 842,300 | 411,587 | 856,044 |
| Income taxes - deferred | 71,978 | 33,627 | 26,905 | 61,288 | 105,311 |
| Accounts receivable | -71,804 | -19,934 | -197,414 | -491,253 | -201,349 |
| Accounts payable and accrued liabilities | -40,164 | 105,685 | 2,302 | 62,287 | 5,291 |
| Other Working Capital | -13,941 | 65,497 | -266,117 | -667,697 | 543,867 |
| Other Operating Activity | -466,543 | -625,645 | -87,179 | 337,340 | -1,502,549 |
| Operating Cash Flow | $2,874,985 | $1,997,421 | $1,042,849 | $85,820 | $2,435,117 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,246,847 | -863,893 | -553,609 | -225,954 | -1,184,244 |
| Net Acquisitions | -2,433,459 | -2,188,764 | -2,135,345 | -2,064,331 | 894,853 |
| Other Investing Activity | 1 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,680,305 | $-3,052,657 | $-2,688,954 | $-2,290,285 | $-289,391 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,140,842 | 992,225 | 320,679 | 106,208 | 1,025,439 |
| Debt Issued | 3,876,102 | 1,767,906 | 1,431,718 | 470,741 | 723,230 |
| Debt Repayment | -2,483,046 | -1,766,430 | -328,699 | -19,787 | -1,270,997 |
| Common Stock Issued | 17,768 | 12,932 | 11,899 | 168 | 55,984 |
| Common Stock Repurchased | -671,772 | -516,476 | -336,052 | -101,593 | -43,958 |
| Dividend Paid | -728,901 | -394,355 | -398,611 | N/A | -383,634 |
| Other Financing Activity | -1,673,623 | -431,948 | -450,742 | 364,487 | -911,195 |
| Financing Cash Flow | $-522,629 | $-336,147 | $250,191 | $820,225 | $-805,130 |
| Exchange Rate Effect | 53,491 | 78,580 | 20,666 | 36,223 | 38,249 |
| Beginning Cash Position | 2,403,108 | 2,385,943 | 2,411,690 | 2,437,009 | 1,155,147 |
| End Cash Position | 1,128,650 | 1,073,140 | 1,036,443 | 1,088,991 | 2,533,991 |
| Net Cash Flow | $-1,274,458 | $-1,312,803 | $-1,375,248 | $-1,348,017 | $1,378,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,874,985 | 1,997,421 | 1,042,849 | 85,820 | 2,435,117 |
| Capital Expenditure | -1,259,766 | -876,009 | -558,694 | -228,124 | -1,248,643 |
| Free Cash Flow | 1,615,219 | 1,121,412 | 484,155 | -142,304 | 1,186,474 |